ArticleInvestigational new drugs2015

Pharmacokinetic drug-drug interaction study of the angiopoietin-1/angiopoietin-2-inhibiting peptibody trebananib (AMG 386) and paclitaxel in patients with advanced solid tumors.

Jennifer R Diamond et al.PubMed ↗Publisher ↗

No numbers read from the abstract.